Biotech China 2014
Cardiovascular Research Technologies (CRT) 2013 DES Bioabsorbable and DCB Technologies


Washington, District of Columbia
http://www.crtmeeting.org/default.aspx
Cardiovascular Research Technologies (CRT) 2013 will take place 
from February 23 - 26, 2013 in Washington DC. This year’s conference 
will be the most comprehensive to date. CRT 2013 has many 
new and exciting features, including a new, cutting-edge Valve & Structural 
Heart track, in addition to its standard five subject areas -- Coronary, Endovascular, Science, Technology and Nurse & Tech. 
Also new this year will be the Essentials of Clinical Research course as well as more exciting hands-on workshops and simulations.

Schedule of Presentations:

Monday, February 25, 2013
08:00:00 DES Bioabsorbable and DCB Technologies | Abstract Café
08:55:00 DES Bioabsorbable and DCB Technologies | DES THROMBOSIS AND DAPT Ajay J. Kirtane, Adnan Kastrati
09:00:00 DES Bioabsorbable and DCB Technologies | DES Thrombosis: Is it Still a Problem in 2013? Ajay J. Kirtane
09:10:00 DES Bioabsorbable and DCB Technologies | Dual Antiplatelet Therapy After DES: When Is it Safe to Stop? US Perspective Roxana Mehran
09:20:00 DES Bioabsorbable and DCB Technologies | Dual Antiplatelet Therapy After DES: When Is it Safe to Stop? OUS Perspective Adnan Kastrati
09:30:00 DES Bioabsorbable and DCB Technologies | Neoatherosclerosis Post BMS and DES Renu Virmani
09:40:00 DES Bioabsorbable and DCB Technologies | Can Systematic Testing for Genomic and Responsiveness to Antiplatelet Therapy Reduce Stent Thrombosis? - Pros and Cons George Dangas
09:45:00 DES Bioabsorbable and DCB Technologies | DES DURABLE POLYMERS George Dangas
09:50:00 DES Bioabsorbable and DCB Technologies | Lessons from the PROTECT Trial Robert Schwartz, Adnan Kastrati
10:05:00 DES Bioabsorbable and DCB Technologies | Longitudinal Stent Deformation Is It a Class Effect? Jeffrey J. Popma
10:20:00 DES Bioabsorbable and DCB Technologies | Break
10:35:00 DES Bioabsorbable and DCB Technologies | Medtronic CardioVascular, Inc.
10:40:00 DES Bioabsorbable and DCB Technologies | Abbott Vascular Charles A. Simonton
10:45:00 DES Bioabsorbable and DCB Technologies | Boston Scientific Corporation Keith D. Dawkins
10:55:00 DES Bioabsorbable and DCB Technologies | The Elixir Biodegradable Polymer Program Stefan Verheye
11:00:00 DES Bioabsorbable and DCB Technologies | THE DES BIODEGRADABLE COATING SYMPOSIUM Marco A. Costa
11:05:00 DES Bioabsorbable and DCB Technologies | Do Biodegradable Polymers Have an Advantage? Renu Virmani
11:15:00 DES Bioabsorbable and DCB Technologies | The Synergy Biodegradable Program and the EVOLVE Clinical Trials Ian T. Meredith
11:25:00 DES Bioabsorbable and DCB Technologies | Orsiro: Biotronik’s PLLA/Sirolimus Biodegradable DES Program Ron Waksman
11:35:00 DES Bioabsorbable and DCB Technologies | EXCELLA Novolimus Elution from PLLA Polymer-Coated Stents Alexandre Abizaid
11:45:00 DES Bioabsorbable and DCB Technologies | The Micell Technology Program and Update
11:55:00 DES Bioabsorbable and DCB Technologies | Combo: A Combination of Sirolimus-Eluting Biodegradable Polymer and Anti-CD34 Antibody Coated Stent Marco A. Costa
12:05:00 DES Bioabsorbable and DCB Technologies | Will Biodegradable Polymers Outperform Durable Polymers? Adnan Kastrati
12:15:00 DES Bioabsorbable and DCB Technologies | Panel Discussion: Will Biodegradable Polymers be the Future of DES? Ian T. Meredith, Stefan Verheye, Marco A. Costa, Ron Waksman, Adnan Kastrati
12:30:00 DES Bioabsorbable and DCB Technologies | Lunch and Visit the Exhibitors and Simulators
13:15:00 DES Bioabsorbable and DCB Technologies | Non-Polymeric DES Development: Update on the Drug Filled Stent Josiah N. Wilcox
13:15:00 DES Bioabsorbable and DCB Technologies | NON-POLYMERIC DES DEVELOPMENT Stefan Verheye, Jacques J. Koolen, Alexandre Abizaid
13:25:00 DES Bioabsorbable and DCB Technologies | The BioFreedom Surface Etching Polymer-Free DES System
13:30:00 DES Bioabsorbable and DCB Technologies | BIOABSORBABLE SCAFFOLDING SYMPOSIUM Jacques J. Koolen, Ron Waksman, Andrew Farb, Alexandre Abizaid
13:35:00 DES Bioabsorbable and DCB Technologies | Update on the Development of BVS: Challenges for the Development of Polymeric Biodegradable Scaffolds for Peripheral Vascular Intervention
13:45:00 DES Bioabsorbable and DCB Technologies | Update on the Development of Metallic Biodegradable Scaffolds
13:55:00 DES Bioabsorbable and DCB Technologies | Challenges for the Development of Biodegradable Scaffolds: Insight from the Preclinical Trials Renu Virmani
14:05:00 DES Bioabsorbable and DCB Technologies | Update on the EXTEND Trial Cohort Alexandre Abizaid
14:15:00 DES Bioabsorbable and DCB Technologies | DESolve Stefan Verheye
14:25:00 DES Bioabsorbable and DCB Technologies | The REVA Tyrosine-Derived Polycarbonate Bioabsorbable Scaffold: Program Update and Lessons Learned Alexandre Abizaid
14:35:00 DES Bioabsorbable and DCB Technologies | Update on the BIOSOLVE Clinical Trial Using DREAMS Absorbable Magnesium Scaffold Ron Waksman
14:45:00 DES Bioabsorbable and DCB Technologies | The BVS ABSORB Clinical Trial Program Gregg W. Stone
14:55:00 DES Bioabsorbable and DCB Technologies | Imaging Observations from the Bioabsorbable Technology
15:05:00 DES Bioabsorbable and DCB Technologies | Regulatory Challenges for Biodegradable Scaffolds Approval Andrew Farb
15:15:00 DES Bioabsorbable and DCB Technologies | Break
15:25:00 DES Bioabsorbable and DCB Technologies | THE DRUG COATED BALLOON (DCB) SYMPOSIUM Bruno Scheller , Robert Schwartz
15:30:00 DES Bioabsorbable and DCB Technologies | Impact of Coating Formulation and Antiproliferative Choices on Drug Transfer and Tissue Pharmacokinetics Juan F. Granada
15:40:00 DES Bioabsorbable and DCB Technologies | What Does the Data Suggest for the Future Use of DCB for Peripheral Application?
15:50:00 DES Bioabsorbable and DCB Technologies | What Does the Data Suggest for the Future Use of DCB for Coronary Application? Ron Waksman
16:00:00 DES Bioabsorbable and DCB Technologies | Lessons from ISAR DESIRE 3 Adnan Kastrati
16:10:00 DES Bioabsorbable and DCB Technologies | DEB for the De Novo Lesions Indication
16:20:00 DES Bioabsorbable and DCB Technologies | Development of a Drug-Coated Angioplasty Scoring Balloon: Preliminary Results from a First-in-Man Study Gary Gershony
16:30:00 DES Bioabsorbable and DCB Technologies | Future Directions and Development of DCB Systems Bruno Scheller
16:40:00 DES Bioabsorbable and DCB Technologies | Regulatory Requirements for DCB Andrew Farb
16:50:00 DES Bioabsorbable and DCB Technologies | Panel Discussion: Will DCB Play a Role in Interventional Cardiology? If So, for Which Indication? Juan F. Granada, Ron Waksman, Robert Schwartz, Rembert Pogge Von Strandmann, Andrew Farb
17:20:00 DES Bioabsorbable and DCB Technologies | Adjourn
22:35:00 DES Bioabsorbable and DCB Technologies | DES PIPELINE REPORT FROM THE US INDUSTRY Michael Joner, George Dangas
4th Annual Pharma R&D Asia Congress
About Us | Privacy Policy | Site Map | FAQs | Advertise With Us | Community
BiotechScienceNews.com promotes research and ranks life scientists working in the life science spectrum involving biotechnology,
drug discovery, genomics, microbiology, neuroscience, medicine, pharmacology, cell biology, and molecular biology.